Supercomputers, Shadow Acquisitions, and AI-Designed Drugs

In today’s AI in Flow, we unpack a blockbuster day in AI: Elon Musk claims xAI could outpace Google by scaling up to 200,000 Nvidia H100s in a bid to dominate infrastructure and data. But with that much compute comes serious environmental questions. Amazon, meanwhile, pulls off a strategic ‘reverse acquihire’ of AGI Labs and Adept without a formal acquisition — raising regulatory eyebrows. Claude Code from Anthropic is turning heads among developers, AI agents race toward autonomy, and Nvidia brings edge AI to the forefront with the Jetson AGX Thor. Plus, MIT uses AI to design new antibiotics, signaling a breakthrough in biomedical innovation. Tune in for the latest moves, risks, and wildcards shaping the AI landscape.About Six & FlowSix & Flow is a digital transformation consultancy helping businesses adapt, grow, and thrive in a fast-changing world. We specialise in AI, CRM, and revenue operations, blending strategy, technology, and creativity to deliver measurable impact. From scaling startups to global enterprises, we partner with ambitious teams to unlock growth through smart automation, customer-centric marketing, and forward-thinking sales enablement. Learn more at sixandflow.com. Hosted on Acast. See acast.com/privacy for more information.